Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
3,762
datasets available to search
ShareScore release 0.9.0
Dataset results
3,762 results for “Combination treatment”
Trans-catheter Chemo-embolization Combined With rAd-p53 Gene Injection in Treatment of Advanced Hepatocellular Carcinoma
ClinicalTrials.gov study NCT02418988. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study Comparing the Efficacy and Safety of Zanidatamab to Trastuzumab, Each in Combination With Physician's Choice Chemotherapy, for the Treatment of Participants With Metastatic HER2-positive Breas
ClinicalTrials.gov study NCT06435429. IPD Sharing: NO. Countries: 15. Publications: 0.
Ph II Trial of a Novel Anti-angiogenic Agent in Combination With Chemotherapy for the Second-line Treatment of Metastatic Colorectal Cancer
ClinicalTrials.gov study NCT00851045. IPD Sharing: Not stated. Countries: 3. Publications: 0.
Polatuzumab, Rituximab and Orelabrutinib Combination Regimen (PRO) in the Treatment of Elderly Frail Patients with Treatment-naive Non-GCB DLBCL
ClinicalTrials.gov study NCT06530511. IPD Sharing: YES. Countries: 1. Publications: 0.
A Clinical Trial of Furmonertinib Combination Therapy As Neoadjuvant Treatment in Resectable EGFR-Mutated NSCLC
ClinicalTrials.gov study NCT06585644. IPD Sharing: NO. Countries: 1. Publications: 0.
CPG10101 Combination Therapy For The Treatment Of Hepatitis C In Non-Responder (Null And Partial Responder) Hepatitis C Virus (HCV) Genotype 1 Infected Subjects
ClinicalTrials.gov study NCT00277238. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of Venetoclax and ABBV-838 Combination Therapy With Dexamethasone in Participants With Multiple Myeloma Whose Cancer Has Come Back or Had No Response to Recent Cancer Treatment
ClinicalTrials.gov study NCT02951117. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Avatrombopag Combined With IST as First-line Treatment for SAA
ClinicalTrials.gov study NCT05720234. IPD Sharing: NO. Countries: 1. Publications: 0.
Darsilide Combined With AI, Trastuzumab and Patuzumab in the Neoadjuvant Treatment of HR+/HER2+ Breast Cancer
ClinicalTrials.gov study NCT06276868. IPD Sharing: NO. Countries: 1. Publications: 0.
DCF Combined With Camrelizumab in the Treatment of Esophageal Cancer
ClinicalTrials.gov study NCT05050760. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study of CDK4/6 Inhibitor Combined With PD-L1 Monoclonal Antibody in the Treatment of PD-1/PD-L1 Resistance and Abnormal Cell Cycle Digestive System Tumors
ClinicalTrials.gov study NCT05139082. IPD Sharing: NO. Countries: 1. Publications: 0.
Venetoclax in Combination With Cladribine and Cytarabine Alternating With Azacitidine Plus Venetoclax for the Treatment of Newly Diagnosed Monocytic AML and Active Signaling Mutated AML
ClinicalTrials.gov study NCT06504459. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Venetoclax in Combination With ASTX727 for the Treatment of Chronic Myelomonocytic Leukemia and Other Myelodysplastic Syndrome/Myeloproliferative Neoplasm
ClinicalTrials.gov study NCT05600894. IPD Sharing: YES. Countries: 2. Publications: 0.
Study of Efalizumab Combined With Intravitreal Ranibizumab in the Treatment of Age-Related Macular Degeneration
ClinicalTrials.gov study NCT00726466. IPD Sharing: Not stated. Countries: 1. Publications: 0.
To Evaluate the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of Disitamab Vedotin Combined With RC98 in the Treatment of Subjects With HER2-expressing Locally Advanced or Metastatic
ClinicalTrials.gov study NCT05514158. IPD Sharing: NO. Countries: 1. Publications: 0.
Camrelizumab Combined With CD30 CAR-T in the Treatment of Relapsed/Refractory CD30+ Lymphoma
ClinicalTrials.gov study NCT05320081. IPD Sharing: NO. Countries: 1. Publications: 0.
Evaluation of Safety and Effectiveness of 2 Lower Dose Combined PDE5i's Versus Single Maximal Dose PDE5i Treatment
ClinicalTrials.gov study NCT01364701. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Azacitidine in Combination With Venetoclax Treatment for MRD Positive Post Allo-HSCT AML/MDS Patients
ClinicalTrials.gov study NCT04809181. IPD Sharing: NO. Countries: 1. Publications: 0.
a Chronobiological Treatment Combining Evening Melatonin and Morning Light Therapy in Idiopathic Hypersomnia: a Prospective, Double Bind, Randomized, Placebo-controlled -Trial
ClinicalTrials.gov study NCT06252571. IPD Sharing: NO. Countries: 1. Publications: 0.
Trial of NP-G2-044 (Prilukae) Combined With PLD for Treatment of Platinum-Resistant Ovarian Cancer (ULTIMUS-1)
ClinicalTrials.gov study NCT07109414. IPD Sharing: NO. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.